{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:25:06Z","timestamp":1786998306224,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.ygyno.2012.12.005","type":"journal-article","created":{"date-parts":[[2012,12,9]],"date-time":"2012-12-09T15:00:34Z","timestamp":1355065234000},"page":"145-153","source":"Crossref","is-referenced-by-count":50,"title":["A novel curcumin-based vaginal cream Vacurin selectively eliminates apposed human cervical cancer cells"],"prefix":"10.1016","volume":"129","author":[{"given":"Priya Ranjan","family":"Debata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario R.","family":"Castellanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmie E.","family":"Fata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Baggett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sritha","family":"Rajupet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Szerszen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sultana","family":"Begum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Mata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vundavalli V.","family":"Murty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne M.","family":"Opitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Probal","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2012.12.005_bb0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ygyno.2012.12.005_bb0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0002-9343(97)00177-0","article-title":"Epidemiology of genital human papillomavirus infection","volume":"102","author":"Koutsky","year":"1997","journal-title":"Am J Med"},{"key":"10.1016\/j.ygyno.2012.12.005_bb0015","author":"National Cancer Institute"},{"key":"10.1016\/j.ygyno.2012.12.005_bb0020","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/00128360-200004040-00004","article-title":"Vulvar vestibulitis: response to hypocontactant vulvar therapy","volume":"4","author":"Fowler","year":"2000","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.ygyno.2012.12.005_bb0025","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0029-7844(03)00741-5","article-title":"Pregnancy outcome after loop electrosurgical excision procedure: a systematic review","volume":"102","author":"Crane","year":"2003","journal-title":"Obstet Gynecol"},{"issue":"33","key":"10.1016\/j.ygyno.2012.12.005_bb0030","first-page":"e1","article-title":"Loop electrosurgical excision of the cervix and subsequent risk for spontaneous preterm delivery: a population-based study of singleton deliveries during a 9-year period","volume":"201","author":"Noehr","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"42","key":"10.1016\/j.ygyno.2012.12.005_bb0035","first-page":"e1","article-title":"Randomized clinical trial of imiquimod: an adjunct to treating cervical dysplasia","volume":"206","author":"Pachman","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2012.12.005_bb0040","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ygyno.2010.04.002","article-title":"Potential mechanisms for HPV vaccine-induced long-term protection","volume":"118","author":"Stanely","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.12.005_bb0045","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1158\/1078-0432.CCR-08-0024","article-title":"Phase II trial of curcumin in patients with advanced pancreatic cancer","volume":"14","author":"Dhillon","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2012.12.005_bb0050","doi-asserted-by":"crossref","first-page":"6847","DOI":"10.1158\/1078-0432.CCR-04-0744","article-title":"Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance","volume":"10","author":"Sharma","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2012.12.005_bb0055","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/mnfr.200700148","article-title":"Curcumin in cancer management: recent results of analogue design and clinical studies and desirable future research","volume":"52","author":"Steward","year":"2008","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.ygyno.2012.12.005_bb0060","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/mp700113r","article-title":"Bioavailability of curcumin: problems and promises","volume":"4","author":"Anand","year":"2007","journal-title":"Mol Pharm"},{"key":"10.1016\/j.ygyno.2012.12.005_bb0065","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1124\/jpet.108.137455","article-title":"Curcumin structure\u2013function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease","volume":"326","author":"Begum","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ygyno.2012.12.005_bb0070","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1089\/ars.2007.1769","article-title":"Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials","volume":"10","author":"Strimpakos","year":"2008","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.ygyno.2012.12.005_bb0075","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00280-010-1470-2","article-title":"A phase I\/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer","volume":"68","author":"Kanai","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ygyno.2012.12.005_bb0080","first-page":"2895","article-title":"Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or premalignant lesions","volume":"21","author":"Cheng","year":"2001","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ygyno.2012.12.005_bb0085","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/mc.20695","article-title":"Curcumin suppresses human papillomavirus oncoproteins, restores p53, Rb, and PTPN13 proteins and inhibits benzo[a]pyrene-induced upregulation of HPV E7","volume":"50","author":"Maher","year":"2011","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.ygyno.2012.12.005_bb0090","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ejmech.2009.12.002","article-title":"Synthesis, antibacterial and antiviral properties of curcumin bioconjugates bearing dipeptide, fatty acids and folic acid","volume":"45","author":"Singh","year":"2010","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.ygyno.2012.12.005_bb0095","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1128\/JVI.02028-06","article-title":"Dysregulation of the ubiquitin-proteasome system by curcumin suppresses coxsackievirus B3 replication","volume":"81","author":"Si","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.ygyno.2012.12.005_bb0100","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/(SICI)1098-2744(199708)19:4<243::AID-MC5>3.0.CO;2-D","article-title":"Screening the p53 status of human cell lines using a yeast functional assay","volume":"19","author":"Jia","year":"1997","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.ygyno.2012.12.005_bb0105","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/sj.bjc.6602928","article-title":"COSMIC 2005","volume":"94","author":"Forbes","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2012.12.005_bb0110","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/01.pas.0000167363.13771.47","article-title":"Combined p53 and retinoblastoma protein detection identifies persistent and regressive cervical high-grade squamous intraepithelial lesions","volume":"29","author":"Baak","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ygyno.2012.12.005_bb0115","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/jcp.2010.083626","article-title":"The impact of epithelial biomarkers, local immune response and human papillomavirus genotype in the regression of cervical intraepithelial neoplasia grades 2e3","volume":"64","author":"\u00d8vestad","year":"2011","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ygyno.2012.12.005_bb0120","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/modpathol.2010.109","article-title":"Local immune response in the microenvironment of CIN2-3 with and without spontaneous regression","volume":"23","author":"\u00d8vestad","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ygyno.2012.12.005_bb0125","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/gcc.10158","article-title":"Comprehensive molecular cytogenetic characterization of cervical cancer cell lines","volume":"36","author":"Harris","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ygyno.2012.12.005_bb0130","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/gcc.20577","article-title":"Identification of Copy number gain and overexpressed genes on chromosome Arm 20q by an integrative genomic approach in cervical cancer: potential role in progression","volume":"47","author":"Scotto","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ygyno.2012.12.005_bb0135","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/gcc.20703","article-title":"Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer","volume":"48","author":"Narayan","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ygyno.2012.12.005_bb0140","doi-asserted-by":"crossref","first-page":"E569","DOI":"10.1002\/ijc.26479","article-title":"Coupling to a cancer cell-specific antibody potentiates tumoricidal properties of curcumin","volume":"131","author":"Langone","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2012.12.005_bb0145","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.brainres.2009.01.066","article-title":"Curcumin blocks brain tumor formation","volume":"1266C","author":"Purkayastha","year":"2009","journal-title":"Brain Res"},{"key":"10.1016\/j.ygyno.2012.12.005_bb0150","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1095\/biolreprod65.3.680","article-title":"Cellular turnover in the mammary gland is correlated with systemic levels of progesterone and not 17beta-estradiol during the estrous cycle","volume":"65","author":"Fata","year":"2001","journal-title":"Biol Reprod"},{"key":"10.1016\/j.ygyno.2012.12.005_bb0155","series-title":"Joint AACR and ACS meeting \u2014 chemistry in cancer research: the biological chemistry of inflammation as a cause of cancer. San Diego, CA","article-title":"Drug targeting to eliminate breast and brain tumors","author":"Langone","year":"2011"},{"key":"10.1016\/j.ygyno.2012.12.005_bb0160","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1038\/onc.2008.65","article-title":"Loss of p53 induces epidermal growth factor receptor promoter activity in normal human keratinocytes","volume":"27","author":"Bheda","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2012.12.005_bb0165","doi-asserted-by":"crossref","first-page":"e18087","DOI":"10.1371\/journal.pone.0018087","article-title":"HDAC inhibition decreases the expression of EGFR in colorectal cancer cells","volume":"6","author":"Chou","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2012.12.005_bb0170","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/7355_2006_007","article-title":"HDAC inhibition in cancer therapy: an increasingly intriguing tale of chemistry, biology and clinical benefit","volume":"1","author":"Pt","year":"2007","journal-title":"Top Med Chem"},{"key":"10.1016\/j.ygyno.2012.12.005_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-11-144","article-title":"Curcumin-induced HDAC inhibition and attenuation of medulloblastoma growth in vitro and in vivo","volume":"11","author":"Lee","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ygyno.2012.12.005_bb0185","first-page":"303","article-title":"Featured excipient: topical oil-in-water cream bases","volume":"6","author":"Loyd","year":"2002","journal-title":"Int J Pharm Comp"},{"key":"10.1016\/j.ygyno.2012.12.005_bb0190","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1042\/CS20050369","article-title":"Molecular biology of human papillomavirus infection and cervical cancer","volume":"110","author":"Doorbar","year":"2006","journal-title":"Clin Sci"},{"key":"10.1016\/j.ygyno.2012.12.005_bb0195","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1006\/gyno.2000.6053","article-title":"Effect of BPV1 E2-mediated inhibition of E6\/E7 expression in HPV16-positive cervical carcinoma cells","volume":"80","author":"Moon","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.12.005_bb0200","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1128\/JVI.01162-09","article-title":"The human papillomavirus Type 18 E2 protein is a cell cycle-dependent target of the SCFSkp2 ubiquitin ligase","volume":"84","author":"Bellanger","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.ygyno.2012.12.005_bb0205","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.4049\/jimmunol.0803645","article-title":"Reversal of human papillomavirus-specific T cell immune suppression through TLR agonist treatment of Langerhans cells exposed to human papillomavirus type 16","volume":"182","author":"Fahey","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.ygyno.2012.12.005_bb0210","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMoa072685","article-title":"Treatment of vulvar intraepithelial neoplasia with topical imiquimod","volume":"358","author":"van Seters","year":"2008","journal-title":"N Engl J Med"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825812009523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825812009523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T16:29:00Z","timestamp":1643819340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825812009523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0090825812009523"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2012.12.005","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}